A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Roller-coaster healthcare stock Hims & Hers Health ( HIMS -1.34%), whose stock got devastated last week by worries that it ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.